Irisin as a predictor of glucose metabolism in children: Sexually dimorphic effects

European Journal of Clinical Investigation

Volumn 44, Issue 2, 2014, Pages 119-124

  Al Daghri, Nasser M ^a,b   Alkharfy, Khalid M ^a,b,c   Rahman, Shakilur ^a   Amer, Osama E ^a   Vinodson, Benjamin ^a   Sabico, Shaun ^a,d   Piya, Milan K ^d   Harte, Alison L ^d   Mcternan, Philip G ^d   Alokail, Majed S ^a,b   Chrousos, George P ^e  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d UNIVERSITY OF WARWICK   (United Kingdom)

^e UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Children; Dimorphism; Glucose; Irisin

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HORMONE DERIVATIVE; IRISIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; FIBRONECTIN; FNDC5 PROTEIN, HUMAN; GLUCOSE BLOOD LEVEL;

AGE; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CHILD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; MALE; METABOLIC PARAMETERS; PRIORITY JOURNAL; SAGITTAL ABDOMINAL DIAMETER; SCHOOL CHILD; SEX DIFFERENCE; CROSS-SECTIONAL STUDY; HOMEOSTASIS; METABOLISM; PHYSIOLOGY;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; CHILD; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRONECTINS; HOMEOSTASIS; HUMANS; MALE; SEX FACTORS;

EID: 84892483312     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12196     Document Type: Article

References (23)

1. Stengel A, Hofmann T, Goebel-Stengel M, Elbelt U, Kobelt P, Klapp BF. Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity-correlation with body mass index. Peptides 2013;39:125-30.
2. Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol Rev 2004;84:277-359.
3. Seale P, Bjork B, Yang W, Kajimura S, Chin S, Kuang S et al. PRDM16 controls a brown fat/skeletal muscle switch. Nature 2008;454:961-7.
4. Cousin B, Cinti S, Morroni M, Raimbault S, Ricquier D, Penicaud L et al. Occurrence of brown adipocytes in rat white adipose tissue: molecular and morphological characterization. J Cell Sci 1992;103:931-42.
5. Walden TB, Hansen IR, Timmons JA, Cannon B, Nedergaard J. Recruited vs. nonrecruited molecular signatures of brown, "brite", and white adipose tissues. Am J Physiol Endocrinol Metab 2012;302:E19-31.
6. Shan T, Liang X, Bi P, Kuang S. Myostatin knockout drives browning of white adipose tissue through activating the AMPK-PGC1alpha-Fndc5 pathway in muscle. FASEB J 2013;27:1981-9.
7. Wu J, Bostrom P, Sparks LM, Ye L, Choi JH, Giang AH et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 2012;150:366-76.
8. Bostrom P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC et al. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012;481:463-8.
9. Moreno-Navarrete JM, Ortega F, Serrano M, Guerra E, Pardo G, Tinahones F et al. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab 2013;98:E769-78.
10. Huh JY, Panagiotou G, Mougios V, Brinkoetter M, Vamvini MT, Schneider BE et al. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism 2012;61:1725-38.
11. Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldfine AB et al. Identification and importance of brown adipose tissue in adult humans. N Engl J Med 2009;360:1509-17.
12. Gilsanz V, Smith ML, Goodarzian F, Kim M, Wren TA, Hu HH. Changes in brown adipose tissue in boys and girls during childhood and puberty. J Pediatr 2012;160:604-9.
13. Roca-Rivada A, Castelao C, Senin LL, Landrove MO, Baltar J, Crujeira AB et al. FNDC5/Irisin is not only a myokine but also an adipokine. PLoS ONE 2013;8:e60563.
14. Reaven GM. Pathophysiology of insulin resistance in human disease. Phys Rev 1995;75:473-86.
15. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest 2000;106:473-81.
16. Williams DE, Cadwell BL, Cheng YJ, Cowie CC, Gregg EW, Geiss LS et al. Prevalence of impaired fasting glucose and its relationship with cardiovascular disease risk factors in US adolescents, 1999-2000. Pediatrics 2005;116:1122-6.
17. Cali AM, Caprio S. Obesity in children and adolescents. J Clin Endocrinol Metab 2008;93:S31-6.
18. Polonsky K, Sturis J, Bell G. Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus-a genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med 1996;334:777.
19. Alberti K. The clinical implications of impaired glucose tolerance. Diabet Med 1996;13:927-37.
20. Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002;346:802-10.
21. Timmons JA, Baar K, Davidsen PK, Atherton PJ. Is irisin a human exercise gene? Nature 2012;488:E9-10.
22. Kohrt WM, Kirwan JP, Staten MA, Bourey RE, King DS, Holloszy JO. Insulin resistance in aging is related to abdominal obesity. Diabetes 1993;42:273-81.
23. St-Onge M-P, Janssen I, Heymsfield SB. Metabolic syndrome in normal-weight Americans new definition of the metabolically obese, normal-weight individual. Diabetes Care 2004;27:2222-8.